-
Health todayObesity, diabetes and GLP-1 new
Clinical obesity has higher mortality than preclinical obesity in three cohorts
Against adults without obesity or organ dysfunction, clinical obesity had a mortality hazard ratio of 1.69 and preclinical obesity 1.19.
Peer-reviewed -
Health todayObesity, diabetes and GLP-1 new
GLP-1 medication use in US adults in 2025, including compounded versions and dose changes
About one in 10 US adults reported past-year GLP-1 use, and 44% of users changed how they took it.
Agency -
Health todayObesity, diabetes and GLP-1 refines
Lower systolic target in type 2 diabetes did not cut dementia or mild cognitive impairment
A systolic target below 120 mm Hg did not reduce dementia or mild cognitive impairment in type 2 diabetes.
Peer-reviewed -
Health todayCancer refines
GLP-1 receptor agonists and lung cancer in type 2 diabetes with pulmonary nodules
GLP-1 receptor agonists were linked to fewer lung cancers than metformin, but genetic and SGLT2 inhibitor comparisons gave no support.
Peer-reviewed -
Tomorrow's worldInnovation in treatment new
Trevogrumab, with or without garetosmab, against muscle loss on semaglutide in obesity
A phase 2 trial in 975 adults with obesity tested GDF8 and activin A antibodies against semaglutide-related lean mass loss.
Peer-reviewed -
Health todayObesity, diabetes and GLP-1 refines
GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes with obesity
In Clalit's medical records, liraglutide and dulaglutide matched SGLT-2 inhibitors on weight loss but lowered HbA1c more.
Peer-reviewed -
Health todayObesity, diabetes and GLP-1 refines
US cardiovascular risk factors 1999-2023 show rising obesity and diabetes, less smoking
Across 11 NHANES cycles, obesity rose to 57.2% and diabetes to 12.7%, while blood pressure control fell to 21.5%.
Preprint · not peer-reviewed -
Health todayObesity, diabetes and GLP-1 refines
Clinical obesity framework classes most BMI-defined obesity at age 46 as pre-clinical
In 6,978 British Cohort Study members aged 46, only 31.4% with BMI-defined obesity met clinical obesity criteria.
Peer-reviewed -
Data, models and systemsValue in health new
Vitamin D for US adults with prediabetes saved costs in a lifetime microsimulation model
In a simulated US cohort with prediabetes, daily vitamin D3 lowered lifetime costs by $3208 per person and added 0.12 QALYs, assuming the 15% cut in diabetes risk seen in pooled trials.
Peer-reviewed -
Health todayObesity, diabetes and GLP-1 refines
GLP-1 receptor agonists and lower heart failure admission or death in diabetic HFrEF
In diabetic HFrEF, GLP-1 RA use had a 12-month risk ratio of 0.58 for heart failure admission or death.
Preprint · not peer-reviewed -
Health todayObesity, diabetes and GLP-1 refines
Bariatric procedures linked to fewer diabetes complications and deaths than obesity drugs
Bariatric procedures were linked to lower 5-year nephropathy, retinopathy, cardiovascular events and deaths than obesity management medications.
Peer-reviewed -
Health todayObesity, diabetes and GLP-1 refines
Diagnosed diabetes in Korea rose with age and year, with higher odds in two birth cohorts
In 3.2 million Korean survey respondents, reported diagnosed diabetes rose with age and year and was higher in two cohorts.
Peer-reviewed